Skip to main content
OpenTrials

Clinical trial condition

Actinomycetales Infections

Explore clinical trials studying Actinomycetales Infections. Study availability and eligibility vary by location and protocol.

1,556 public trials 161 recruiting studies
Refine in advanced search Browse all conditions

Actinomycetales Infections trial results

Completed

Prospective Assessment of TBDx Feasibility

NCT02912832

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations
  • Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia Lima, Peru
  • Pham Ngoc Thach Hospital Ho Chi Minh City, Vietnam
View Trial Details
Completed

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

NCT00307567

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
  • GSK Investigational Site Eppelheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
View all 51 locations
View Trial Details
Completed

Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth

NCT00317122

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +20 more
Locations
  • GSK Investigational Site Brits, South Africa
  • GSK Investigational Site Brits, South Africa
  • GSK Investigational Site Centurion, South Africa
  • GSK Investigational Site Ga-Rankuwa, South Africa
View Trial Details
Completed

Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants

NCT00290303

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations
  • GSK Investigational Site Manila, Philippines
  • GSK Investigational Site Quezon City, Philippines
  • GSK Investigational Site Sampaloc, Manila, Philippines
View Trial Details
Completed

Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety

NCT00263692

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site Oakland, California, United States
  • GSK Investigational Site Torrance, California, United States
View all 15 locations
View Trial Details

Related conditions